Wednesday, October 15, 2008

Drop That Corn Dog, Doctor

If doctors aren't making wise choices about their health, what kind of message are they sending their patients?

Claudia Kalb
NEWSWEEK
From the magazine issue dated Oct 13, 2008

I'm not naive when it comes to doctors' diets. I've seen M.D.s eat cookies in hospital cafeterias and gulp down sodas at medical conferences. One of my doctor friends sneaks corn dogs and fried dough at the beach. But even I was surprised when I sat down to dinner with a couple of physicians one night and watched them order the biggest steak platters on the menu. Here were two guys who presumably recognized the ills of dietary fat and clogged arteries, eating an overly rich, wildly caloric meal. Shouldn't they have known better?

On the whole, America's physicians are healthier than the people they take care of. Twenty-one percent of the population smokes; only 4 percent of docs do. And M.D.s are leaner, too. Forty-four percent of male doctors are overweight and 6 percent are obese, according to Harvard's Physicians' Health Study. The rest of America: 65 and 32 percent, respectively. We can all do better.

But doctors are the people we look to for guidance and advice about our health. If they're not making wise choices, what kind of message are they sending us? Studies show that physicians are more likely to counsel patients about good health habits when they're also following the rules. "You can't look a patient in the eye and talk to them about exercising, diet and weight loss if you yourself aren't a role model," says Dr. Ted Epperly, president of the American Academy of Family Physicians.

Dr. David Eisenberg, director of the Osher Research Center at Harvard Medical School, came up with a novel idea: teach doctors how to create "nutritious, yet delicious" meals so that they can, in turn, teach their patients. With diabetes, heart disease and cancer plaguing this nation, a nutritious diet is "as essential as any prescription drug or surgery," says Eisenberg, who developed a passion for cooking as a child when he spent weekends in his father's bakery. Last month some 300 health-care professionals, most of them physicians, gathered in Napa Valley to attend Eisenberg's brainchild, Healthy Kitchens, Healthy Lives, a collaboration between Harvard and the Culinary Institute of America. They listened to scientists talk about healthy carbs and phyto-nutrients. They received guidance on the basics—how to hold a knife, how to measure portion size. And they learned how to eat mindfully, savoring flavor, texture and taste.

Dr. Rajani LaRocca attended an earlier session in April and went home inspired. Plenty of LaRocca's patients at a community health center in Charlestown, Mass., want to lose weight, but too often they look for an easy out. "People come in and ask, 'Is there a pill?' " she says. A couple of weeks ago, LaRocca and her colleagues put on a healthy-cooking demonstration for their patients, teaching them that olive and canola oils are "good" fats—something many doctors still don't know, according to a survey of physicians published in Nutrition Journal. "You have to change the basic way you think about food," says LaRocca.

Medical professionals must change the way they think about themselves, too—and early on. Dr. Jo Marie Reilly, of the Keck School of Medicine of the University of Southern California, has seen the negative impact that doughnut-eating, sedentary young M.D.s can have on their clinic population. Patients will say, "This doctor is telling me to lose weight and exercise more, but look how he looks," Reilly says. Reilly's first-year med students must fill out a "physician wellness contract" stating their personal health goals. Yohualli Balderas-Medina, 23, committed to running regularly and maintaining close ties with friends and family, which can reduce stress and lead to better health outcomes. She's done both, and says she feels "healthy and motivated." A great beginning for a future doc and her patients.

URL: http://www.newsweek.com/id/162334

Sunday, October 12, 2008

VM Oct 3: Resuscitating the Extremely Low-Birth-Weight Infant: Humanitarianism or Hubris?

Pressure exists to resuscitate younger and smaller preterm babies, but ability to predict how the earliest and tiniest will fare if they survive is limited.

Patrick M. Jones, MD, MA, and Brian S. Carter, MD

In any complex, controversial topic, attempts at open dialogue run the risk of shipwrecking on the shore of preconceived, deeply held opinion. For example, walk into a room that contains people at opposite ends of the political spectrum and toss out the phrase "universal health care." If we had the ability to project their initial reactions onto a screen, they would range from a Technicolor utopian society, dancing hand-in-hand with their health care providers to a stark, gray picture of huddled masses in long outdoor lines awaiting their catheterization for emergent cardiac failure. In a similar way, reactions vary when the phase "resuscitation of a 24-weeker" is uttered in mixed health-professional company. On one side of the spectrum a person will see the advances in neonatal care that allow a disease (respiratory distress syndrome) that killed President Kennedy's son only 45 years ago to be consistently and successfully treated today in a premature child born to the least advantaged of our society. Others, should they include pediatric and family physicians, will harken back to their residency days and recall the former premature infant who lived all 6 months of its life on a ventilator in the hospital's neonatal intensive care unit.

Learning Objective Identify sources of the pressure to resuscitate ever-younger and smaller preterm babies and the limits to medicine’s ability to predict how the earliest and tiniest will fare if they survive.

Providing intensive care to extremely low-birth-weight infants (birth weight of less than 1 kilogram) and extremely premature infants (infants born between 22 and 25 weeks' gestation) raises many questions: (1) Who benefits, and when do these benefits cease? (2) Does survival come at any and all costs to the patients, their families, and the health care staff? (3) And is a technology-dependent child truly reaping what is in his or her best interest?

With the birth, growth, and development of the bioethics community during the last 60 years, these questions have entered the public forum, and neonatology has at times found itself to be the perceived "poster-child" for medical hubris—aggressively treating any newborn, ethical concerns be damned. No doubt, parts of the complex technical, sociopolitical, and ethical history of neonatology moved clinical innovation, research, and practice in this direction [1], but we would argue that this history is neither unparalleled nor limited to neonatology. Indeed, all realms of critical care medicine have struggled with these and similar questions, yet a cloud of prejudice lingers over neonatology, casting its life-saving work into shadow and hiding the complexity of decisions made on behalf of extremely premature infants by families and physicians. The brevity of this article prohibits an in-depth discussion of the history and literature on resuscitation of increasingly smaller and younger premature infants. Nevertheless, it is our hope that we can guide the reader through some commonly held notions about neonatology that will serve as an impetus for identifying preconceived notions or biases, reflecting on the matter in a more informed manner, and considering a reexamination of this topic's complexities.

Neonatology Constantly Pushes the Line of Viability Downwards

Not really. In fact, the results of neonatologists' ability to save infants as young as 23 weeks' gestational age has been facilitated by a few major advances in applied technology, pharmaceuticals and procedures—not a gradual and persistent push toward saving younger and younger babies. These advances have occurred in a manner described by the evolutionary concept of punctuated equilibrium—large shifts in the evolution of a species followed by small incremental improvements until the next big shift. For neonatology, those shifts have been the advances in thermal regulation; modification of mechanical ventilators developed for adults for use with newborns (improved initially by the addition of end-expiratory pressure, and later—with the advent of microcircuit technology—by the capability to synchronize respirations with the neonatal patient); discovery and utilization of prenatal steroids on fetal lung development (so that this obstetrical intervention contributes largely to improved neonatal outcomes); and the development of exogenous surfactant for the treatment of respiratory distress syndrome.

Presently, we are limited in sustaining life for fetal neonates by the developmental biology of the lung and its circulation. This limit will most likely persist inasmuch as further ability to support cardiopulmonary function in the smallest and youngest newborns is not foreseeable without disrupting vital organ development. Since the advent of surfactant therapy 18 years ago, clinical research has not for the most part resulted in the ability to save ever-younger babies. The very real limits of fetal biological development force neonatologists and others to question the appropriateness of attempting to sustain extra-uterine life when the costs borne by the patient (organ system maldevelopment or failure) argue for considering not simply survival but the quality of the life saved. Hence, the bulk of research in recent years has been directed towards producing better long-term outcomes for newborns who survive prematurity.

Neonatologists Compete to Save the Smallest Premature Infant

Media attention garnered by certain medical centers upon graduating another in a series of "tiniest babies" saved, makes one wonder whether each NICU has a plaque with a revolving set of numbers that change to announce the weight of its smallest baby saved. The senior author on this paper (BC) has failed to interact with any colleague over the past 20 years at four major medical centers who boasted of saving the smallest baby. Nor has the neonatal fellow (PJ), who has trained at three separate institutions in the past 10 years, had any such interaction. In other words, it is not neonatologists who promote such feats.

The greatest pressure to resuscitate extremely premature infants often comes from outside NICUs. In our health care system, NICUs are substantial revenue generators for hospitals and academic medical centers. As a result, there is a tendency to market women's and infant services in hospitals that have NICUs. The marketing can be done discreetly and with evidence-based local outcomes, or blatantly with large billboards strategically placed on main thoroughfares in a community or in newspaper, television, or Internet advertisements—replete with the seemingly obligatory photo of a tiny baby held in the palm of someone's hand. Considering that health care dollars expended in neonatal services reap more long-term rewards than those spent at any other time in life and with the lowest cost-per-year of life gained [2], the idea for marketing neonatal services comes from offices other than those of neonatologists. The result, however, is that families understandably come to us with the expectation that their premature infant will be as advertised: tiny, cute, and healthy.

Neonatologists Know the Abysmal Outcomes for these Infants, but Push on Regardless

Outcome data is available, but the field is still developing. Making use of follow-up data, investigators are gradually adding to the knowledge base of outcomes for extremely low-birth-weight and early gestation infants [3-6]. The absolute number of these patients is very small (less than 0.5 percent of all U.S. births), and a large number (up to 50 percent, depending upon gestational age) of them die prior to discharge from the NICU. As a result, few infants remain to be tracked in neonatal follow-up clinics that collect information and perform longitudinal neurodevelopmental testing (generally over no more than 2 to 7 years). The follow-up is poorly organized and underfunded in the United States, and, because of this, the existing extremely low-birth-weight outcome literature is based on relatively few numbers. The neonatologist's capacity to prognosticate the outcome for a premature infant, then, is not generally comparable to that of his or her adult medicine colleague who addresses more common, thoroughly studied diseases in larger populations.

Predicting the individual outcome for most extremely low-birth-weight infants remains elusive. Patient information is at times difficult to discover. Depending on a mother's access to and utilization of prenatal care services, estimates of an infant's gestational age can be unreliable. Furthermore, birth weight can vary due to factors other than developmental maturity, allowing children of the same weight to have markedly different chances for survival. But even when all of the desired patient information is available, clinicians are left with the fact that population-based predictions only provide an estimate of outcomes that may or may not accurately reflect the morbidity and mortality risk for any extremely low-birth-weight infant [7].

Two bodies of work that reveal this difficulty are Ambalavanan's attempt to use multiple logistic regression and neural network models to predict extremely low-birth-weight death [8] and Meadow's research on caregiver intuition regarding an individual patient's survival to discharge [7, 9]. While neonatologists may be able to tell prospective parents that, in general, the 22-week gestational age infant will almost certainly die and the 26-week infant will likely do well, they are not good at predicting the individual outcomes of those who fall in between these age brackets.

Even if our predictive abilities were excellent, there would still be limitations to its use.Parents have an understandable habit of hoping. Should a clinician's ability to predict death or severe disability for an individual patient be so accurate that he or she was wrong only 10 percent of the time, it would still mean to the family that its child had a 1-in-10 chance of living or not being severely disabled. What risk threshold is acceptable and who decides? Do clinicians—as both members of society and the community of health care professionals—stand ready to refuse intensive care to a patient, regardless of the family's wishes? And does giving outcome data to families facilitate their decision-making capabilities [10]?

Conclusion

The dilemmas over resuscitation of extremely low-birth-weight infants reach far beyond the medical profession's obsession with technology (no more present in neonatology than elsewhere in modern medicine), misleading media stories of the tiniest survivor, and forgoing the best interest of the patient to satisfy a family's or physician's agenda. These issues cut to the heart of the human questions that permeate medicine: (1) Who decides best-interest? (2) Who speaks for patients when they cannot speak for themselves? (3) What constitutes futile care? (4) And can we even define the word "futile" in the same manner for persons of different age or religious, educational, socioeconomic, and cultural backgrounds?

Recognizing this complexity allows us to approach the question of infant resucitation with less hubris and more humanitarianism, humility, and compassion—appreciating why physicians and families continue to struggle to make resuscitation decisions for extremely low-birth-weight infants.


References

  1. Lantos JD, Meadow WL. Neonatal Bioethics: The Moral Challenges of Medical Innovation. Baltimore: Johns Hopkins University Press; 2006.
  2. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006;355(9):920-927.
  3. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkerson AR. The EPIcure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics. 2000;106(4):659-671.
  4. Marlow N, Wolke D, Bracewell MA, Samara M ; EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005; 352(1):9-19.
  5. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med. 2000;343(6):378-384.
  6. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD ; National Institute of Child Health and Human Development Neonatal Research Network. Intensive care for extreme prematurity—moving beyond gestational age. N Engl J Med. 2008;358(16):1672-1681.
  7. Meadow W, Frain L, Ren Y, Lee G, Soneji S, Lantos J. Serial assessment of mortality in the neonatal intensive care unit by algorithm and intuition: certainty, uncertainty, and informed consent. Pediatrics. 2002;109(5):878-886.
  8. Ambalavanan N, Carlo WA, Bobashev G, et al. Prediction of death for extremely low birth weight neonates. Pediatrics. 2005;116(6):1367-1373.
  9. Meadow W, Lagatta J, Andrews B, et al. Just, in time: ethical implications of serial predictions of death and morbidity for ventilated premature infants. Pediatrics. 2008;121(4):732-740.
  10. Boss RD, Hutton N, Sulpar LJ, West AM, Donohue PK. Values parents apply to decision-making regarding delivery room resuscitation for high-risk newborns. Pediatrics. 2008;122(3):583-589.

Additional Suggested Reading

  • Carter BS, Stahlman M. Reflections on neonatal intensive care in the U.S.: limited success or success with limits? J Clin Ethics. 2001;12(3):215-222.
  • Singh J, Faranoff J, andrews B, et al. Resuscitation in the "gray zone" of viability: determining physician preferences and predicting infant outcomes. Pediatrics. 2007;120(3):519-526.

Patrick M. Jones, MD, MA, is a clinical fellow in neonatology at Monroe Carell Jr. Children’s Hospital at Vanderbilt University Medical Center. He has a medical degree from Baylor College of Medicine and a master’s degree in bioethics from the University of Virginia. His research interests include end-of-life decision making and the provision of health care to children with life-threatening or life-limiting disease.

Brian S. Carter, MD, is a professor of pediatrics (neonatology) at Vanderbilt University Medical Center and sees patients at the Monroe Carell, Jr. Children’s Hospital at Vanderbilt in Nashville, Tennessee. He serves on the VUMC Ethics Committee and has long been involved in bioethics and palliative care education.

Sunday, October 5, 2008

VM Oct 2: Physician and Parental Decision Making in Newborn Resuscitation

Clinical facts and physicians’ ethical obligations are critical in resolving disagreements between parents and physicians about resuscitation of an extremely premature infant.

Commentary by Eric C. Eichenwald, MD, Frank A. Chervenak, MD, and Laurence B. McCullough, PhD

An ultrasound performed on a woman who was 23 weeks pregnant revealed multiple findings suspicious for trisomy 21 syndrome, (Down syndrome). The woman and her husband were devastated, saying they could not possibly raise a child with mental retardation and physical anomalies, and they requested a termination. The obstetrician recommended amniocentesis for chromosomal analysis that would give definitive diagnosis of trisomy 21, and the test was performed. The parents said they planned to terminate the pregnancy if the results of the chromosome analysis confirmed Down syndrome.

Learning Objective: Identify the clinical facts and ethical obligations of physicians that are critical in resolving disagreements between parents and physicians about resuscitation of an extremely premature infant.

Before the results were returned, the woman arrived at the labor and delivery unit with a tender abdomen, purulent discharge from the cervix, and high fever. She appeared to have an acute intrauterine infection from the amniocentesis procedure. Antibiotics were started, but it soon became clear that the woman was becoming septic; the obstetrician on call recommended rapid delivery of the fetus. The woman and her husband again clearly stated that they wanted no resuscitation performed on the infant after delivery. The couple and the physicians agreed that, given the probability of a severely anomalous infant, the plan would be to provide only comfort care measures.

The woman's labor was induced and she delivered a liveborn female infant, surprisingly robust. The infant had a strong cry, kicked vigorously, and was much larger than anticipated. The neonatologists examining the infant found themselves reconsidering their decision to withhold resuscitation. Suddenly the seemingly certain prenatal diagnosis of Down syndrome appeared implausible, given the appearance of a strong infant without apparent anomalies. The NICU team realized that, under any other circumstance, resuscitation measures would be well under way; they became uneasy as they watched the premature infant's forceful kicking and energetic cries. Within minutes to hours the female infant's lungs would tire and she would die without respiratory support.

The physicians announced to the parents their decision to reverse their previous plan to withhold care based on the healthy appearance of the neonate. The neonatologist described the resuscitation measures they planned to begin. The parents were infuriated. "We had an agreement," the father retorted. "My wife and I made it very clear to you that we cannot manage an impaired child. This is our decision to make—we're the parents, and it is your duty to respect our wishes."

Commentary 1

by Eric C. Eichenwald, MD

Decisions about whether to provide intensive care to periviable infants remain some of the most difficult in neonatology. These decisions do not occur in a vacuum; rather they are complex interactions among parental concerns and rights; societal norms, which may be regional rather than national; and the neonatologist's opinions about viability and medical futility. The case presented is an excellent example of the potential conflicts among these competing demands, and it helps focus some of the issues surrounding prenatal consultation and parental decision making.

Clinical Facts

So, what are the facts about outcomes of extreme prematurity? We know that below a certain gestational age (approximately 22 weeks), because of immaturity of the major organ systems, death is certain even with aggressive care—hence, providing intensive care is medically futile. With advancing gestational age, the chances of survival increase, though this may come at the cost of significant long-term morbidity, especially in those infants born between 23 and 24 weeks' gestation. For example, in the Vermont Oxford Network (a voluntary network for data collection in more than 650 neonatal intensive care units in the U.S. and abroad), among infants born between 1996 and 2000 with a birth weight of 401 to 500 grams and a mean gestational age of 23.2 weeks, mortality was 83 percent, and survivors often had serious short-term medical complications [1]. The EPICure study reported outcomes for all infants born at a gestational age of 20 to 25 weeks over a 10-month period in 1995 in the U.K. and Ireland. Only 811 of the 4,004 infants (20 percent) received intensive care, and 39 percent of those survived to discharge [2]. Of the survivors, 16.5 percent had ultrasonographic evidence of severe brain injury. Of these surviving infants who were evaluated at 30 months of age, half had a motor, cognitive, or neurosensory disability; in approximately one quarter of the children, the disability was considered severe.

The National Institutes of Child Health and Development Neonatal Research Network recently analyzed outcomes at 18 to 22 months of age of 4,446 infants born between 22 to 25 weeks' gestation at 19 centers in the United States [3]. Of these, 83 percent received intensive care in the form of mechanical ventilation. Of the infants for whom outcome could be determined, 49 percent died, 61 percent died or had profound impairment, and 73 percent died or had impairment (defined as mental retardation, moderate or severe cerebral palsy, blindness, or deafness). Factors in addition to gestational age that were found to affect a favorable outcome to intensive care included being female, exposure to antenatal corticosteroids, singleton gestation, and birth weight. A web-based tool to approximate survival without impairment based on these data is available at the National Institutes of Health web site [4].

How Neonatologists Act on These Facts

How do neonatologists interpret these data when it comes to decisions in the delivery room about resuscitation of an individual infant? A cross-sectional survey of 149 practicing neonatologists in six New England states queried attitudes about whether intensive care was beneficial at different gestational ages [5]. At or below 23-0/7 weeks gestation, 93 percent of the reporting neonatologists considered treatment futile. In contrast, at 24-1/7 to 24-6/7 weeks and 25-1/7 to 25-6/7 weeks' gestation, 41 percent and 84 percent of respondents, respectively, considered treatment beneficial. When asked to consider parental requests, 91 percent of the neonatologists responding reported that they would resuscitate in the delivery room despite parental requests to withhold treatment if they considered treatment to be clearly beneficial. When respondents considered treatment to be of uncertain benefit, 100 percent reported that they would resuscitate if parents requested, 98 percent reported that they would resuscitate if parents were unsure, and 76 percent reported that they would follow parental requests to withhold. Thus, while parents' requests about their infant's resuscitation influence the neonatologist's decision making in the delivery room, these decisions are also heavily influenced by the physicians' beliefs about the gestational age bounds of clearly beneficial care, which are strikingly variable among physicians.

These data reinforce the need for prenatal consultation with parents prior to the expected delivery of an extremely preterm infant. In the same survey of New England neonatologists, respondents were queried as to the content of prenatal consultation [6]. The results showed that neonatologists consistently discussed the clinical issues anticipated with the expectant parents, but they varied when it came to discussing the social and ethical issues surrounding an extreme preterm birth. Of note, while 77 percent of the neonatologists surveyed indicated they thought that decisions about withholding resuscitation should be made jointly with parents, only 40 percent said that the decision is made by both parties in actual practice.

While it is clear that the consulting neonatologist's beliefs about the benefits of providing intensive care influence how the consultation is performed, it is also evident that how the message is framed to parents influences decisions. In a survey of adult volunteers, a hypothetical vignette of a threatened delivery at a gestational age of 23 weeks was given to participants [7]. Respondents were randomly assigned to receive the same prognostic outcome information framed as either likelihood of survival with lack of disability (positive frame) or the chance of dying and likelihood of disability (negative frame), and asked to decide on resuscitation or comfort care. Overall, 24 percent of respondents chose comfort care, and 76 percent chose resuscitation. More participants chose to provide comfort care rather than resuscitation when the vignette was presented in a negative frame.

In practice, because of the uncertainty surrounding outcomes in periviable infants, after prenatal consultation even, many parents are unable to state definitively whether they desire resuscitation or not. In these circumstances, it is left to the neonatologist to decide whether to intervene in the delivery room. Many neonatologists use their initial assessment of the infant at birth and the response to initial resuscitative efforts to help them decide whether to proceed with further intensive care. In a study of outcomes of infants with a birth weight equal to or less than 750 grams, proxy measures of "how the infant looked" in the delivery room (Apgar scores and heart rate at one and five minutes) "were neither sensitive to nor predictive of death before discharge, survival with neurologic disability, or intact neurologic survival" [8].

Guiding Principles for Decision Making

Where are we left with these difficult decisions about what to do in the delivery room when a periviable infant is born? First, prenatal consultation should provide the expectant parents with factual information about survival and outcomes, unfettered by the neonatologist's personal beliefs. Second, it is essential that the parents' beliefs and attitudes about quality of life be sought and understood. Finally, respect for the parents as decision makers for their unborn infant must form the basis for these conversations. It must remain clear, however, that after the infant's birth, the neonatologist's first duty is to his or her patient—the newly born infant. While the judgment to offer resuscitation to an individual infant should be heavily influenced by the parents' wishes, if clinical circumstances are found to be different after birth than was expected, the physician must first consider the rights of the baby.

This case presents exactly that dilemma—a prenatal diagnosis which is unconfirmed, and an infant perhaps more mature and vigorous than expected. Here, several errors may have been made which influenced the parental decisions. It is unclear whether the parents were provided a sense of the uncertainty of the diagnosis of trisomy 21 based on the ultrasound findings. Many findings "associated" with an aneuploidy may also be seen in a normal fetus. When the mother developed chorioamnionitis after the amniocentesis, the decision to resuscitate the infant needed to be reconsidered and discussed with the parents in the context of what to do if the diagnosis of trisomy 21 was incorrect. It is possible that the parents, when provided with the full information about the outcomes of extreme prematurity, might have chosen resuscitation in the absence of a chromosomal abnormality.

Lastly, as is true for any prenatal consultation, uncertainty about the gestational age needs to be clarified—it is clear that differences of 1 week of gestation can profoundly alter outcome and influence the decision to provide intensive care. While the neonatologist does indeed have a duty to respect the parents' wishes, he or she also has an obligation to provide care that is, in his or her opinion, beneficial to the baby. I would argue in this case, since the gestational age of the infant is certain to be 23 weeks or less, our knowledge of outcomes would swing the first duty to the parent's strongly expressed wishes for no resuscitation, and, regardless of the condition of the infant after birth, comfort care would be appropriate.


References

  1. Lucey JF, Rowan CA, Shiono P, et al. Fetal infants: the fate of 4172 infants with birth weights of 401 to 500 grams–the Vermont Oxford Network experience (1996-2000). Pediatrics. 2004;113(6):1559-1566.
  2. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics. 2000;106(4):659-671.
  3. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. Intensive care for preterm newborns—moving beyond gestational age thresholds. N Engl J Med. 2008;358(16):1672-1681.
  4. NICHD Neonatal Research Network (NRN): Extremely Preterm Birth Outcome Data. National Institute of Child Health and Human Development web site. http://www.nichd.nih.gov/about/org/cdbpm/pp/prog%5Fepbo/. Updated April 17, 2008. Accessed August 26, 2008.
  5. Peerzada JM, Richardson DK, Burns JP. Delivery room decision-making at the threshold of viability. J Pediatr. 2004;145(4):492-498.
  6. Bastek TK, Richardson DK, Zupancic JA, Burns JP. Prenatal consultation practices at the border of viability: a regional survey. Pediatrics. 2005;116(2):407-413.
  7. Haward MF, Murphy RO, Lorenz JM. Message framing and perinatal decisions. Pediatrics. 2008;122(1):109-118.
  8. Singh J, Fanaroff J, Andrews B, et al. Resuscitation in the "gray zone" of viability: determining physician preferences and predicting infant outcomes. Pediatrics. 2007;120(3):519-526.

Eric C. Eichenwald, MD, is associate professor of pediatrics at Baylor College of Medicine and medical director of the Newborn Center at Texas Children’s Hospital, both in Houston.

Commentary 2

by Frank A. Chervenak, MD, and Laurence B. McCullough, PhD

This case involves the physician's ethical obligations to a pregnant woman and her husband during pregnancy and also the physician's ethical obligations to a neonatal patient and its parents after liveborn delivery. The difference between these two sets of ethical obligations is crucial for understanding how the team should respond to the refusal of intervention by the child's parents.

The Pregnant Woman as a Patient

The physician's ethical obligations to a pregnant woman are both beneficence-based and autonomy-based. As her fiduciary, i.e., a professional committed to protect and promote her health-related interests, the physician has a beneficence-based obligation to offer, recommend, and perform clinical interventions that are reliably expected to result in the greater balance of clinical goods over clinical harms for the woman in the course of her pregnancy. Pregnant women have their own perspective on health-related and other interests, and the ethical principle of respect for patient autonomy obligates the physician to provide the pregnant woman with the information relevant to her decisions about the clinical management of her pregnancy and then to implement only those clinical interventions that she authorizes as a result of the informed consent process [1].

The Fetus as a Patient

The physician also has beneficence-based obligations to protect and promote the health-related interests of the fetus, but only when the fetus is a patient. The physician does not have autonomy-based obligations to any fetus, because its developmental state does not support the complex psychosocial functioning by virtue of which an individual generates its own moral status. In the language of ethics, the fetus is not capable of generating independent moral status or rights, hence the concept and discourse of fetal rights are best avoided in determining a physician's ethical obligations to a pregnant woman.

The fetus is a patient when it is presented to a physician or other health care professional for clinical interventions. In the language of ethics, the fetus has dependent moral status when there are links between its current existence in utero and its later becoming a child. Before viability (the ability of the fetus to survive ex utero with full technological support) the only link between a fetus and its later becoming a child is the pregnant woman's autonomous decision to confer the dependent moral status of being a patient on her fetus. Prior to viability the pregnant woman is free to withhold conferring moral status or, having conferred it, to withdraw it.

When a woman presents herself to a physician or other health care professional after viability (typically after 24 weeks' completed gestation by reliable ultrasound dating), the fetus is a patient, and the physician has beneficence-based obligations to protect and promote its health-related interests. We emphasize that the fetus is not a separate patient, because these beneficence-based obligations must always be balanced against the physician's autonomy-based and beneficence-based obligations to the pregnant woman [1].

It is well accepted in obstetric ethics that a pregnant woman is free to withdraw the conferred moral status of being a patient from a previable fetus whether the fetus has an anomaly or not. Therefore, a woman is free to continue or end her pregnancy in either case. When there is a suspicion of trisomy 21 with ultrasound late in the second trimester, the obstetrician should attempt to resolve this uncertainty as expeditiously as possible with invasive genetic diagnosis.

In this case scenario, the physician would have been ethically justified to offer the pregnant woman invasive intervention to cause in utero fetal death by intracardiac potassium chloride injection before labor was induced [2]. A major preventive ethics aspect of this case, unmentioned in the scenario, is that this option should have been discussed with the parents by the physician. Because the fetus is previable, the pregnant woman's autonomous decision making determines whether or not it has conferred status as a patient. Had she decided to withdraw the status of being a patient from her fetus at that time, it would no longer have been a patient. Terminating the life of a previable fetus in utero does not violate any professional, beneficence-based obligations to a fetal patient and is therefore permissible in obstetric ethics.

If her pregnancy had continued to viability, then the fetus would have become a patient. We have argued elsewhere that it is permissible to perform an abortion of a viable fetus but only when one of two conditions is met: "a very high probability of a correct diagnosis…[with] either (a) a very high probability of death as an outcome of the anomaly diagnosed or (b) a very high probability of severe irreversible deficit of cognitive developmental capacity as a result of the anomaly diagnosed" [3]. Neither condition, we emphasize, can be competently judged to be met by the presence of Down syndrome, much less the increased risk of Down syndrome. Therefore it would be unethical to perform termination of a viable pregnancy in this context.

The Neonate as a Patient

A fundamental component of the ethical concept of the previable fetus as a patient is that this moral status is a function of the pregnant woman's autonomous decision to confer it. In contrast, infants born alive in the presence of health care professionals become patients independently of the autonomy of their parents. This is because the general ethical concept of being a patient requires only that the human being in question be presented to a physician or other health care professional and that there exist clinical interventions that are reliably expected to result in the greater balance of clinical goods over clinical harms to that human being. Moreover, parents of a liveborn infant become his or her moral fiduciaries, and they, too, are obligated to protect and promote the health-related interests of their child. Thus, a liveborn infant simultaneously acquires two kinds of mutually reinforcing moral status—one as a patient of health care professionals to whom the infant is presented and a second as a child of his or her parents. As their child's fiduciaries, parents have a beneficence-based obligation to authorize clinical intervention when their child's health care professionals have beneficence-based obligations to intervene [4].

Neonatal resuscitation and subsequent neonatal critical care management are understood to be trials of intervention. They are undertaken to achieve the short-term goal of preventing imminent death and the long-term goal of an acceptable clinical outcome. For infants, acceptable outcomes should be understood from a clinical perspective: is continued critical-care intervention reliably expected to preserve some interactive capacity that will support some psychosocial development that is not overwhelmed by the child's condition or the iatrogenic complications of treatment?

The ethical analysis of the neonate's status as a patient has important clinical implications in this case. The outcomes for infants born at reliably estimated 23 weeks' gestation vary according to the infant's sex, its singleton versus multiple status, and administration of steroids [5]. Outcomes also vary by the presence and severity of anomalies [6, 7].

Resuscitation and transfer to the neonatal intensive care unit (NICU) is reliably expected to prevent this neonate's imminent death, hence the short-term goal of clinical intervention, preventing imminent demise, can be reasonably expected to be achieved for this patient.

Concerning the long-term goal of achieving an acceptable clinical outcome, we note that this infant was a singleton and is female, factors that increase her chance of survival and decrease the risk of developmental impairment. In addition, no anomalies have been identified. Even if trisomy 21 had been confirmed by genetic evaluation, that anomaly cannot be reliably predicted to eliminate interactive capacity and psychosocial development; most infants with Down syndrome have mild or moderate mental retardation, both of which are compatible with significant psychosocial development.

The father's express concern that he and his wife are not able to manage an impaired child has uncertain bearing on decision making at this time, because a prediction that their child would be significantly developmentally impaired as a result of extreme prematurity is uncertain. It is ethically impermissible for the team to discontinue clinical management of this neonatal patient at this time, because it cannot be reliably expected that the second goal of critical care intervention—an acceptable clinical outcome—will not be achieved.

The judgment that there is sufficient clinical and ethical justification to resuscitate and transfer the infant to the NICU should be explained to both parents. They should be counseled about continuing clinical management as a trial of intervention that will be reconsidered should evidence-based clinical reasoning subsequently support a prognosis of imminent death that cannot be prevented or of irreversible, profound loss of developmental capacity from the child's condition or iatrogenic complications.

Another preventive ethics aspect of this case is that both parents should be informed prior to birth, that when physicians and other health care professionals have a fiduciary, beneficence-based obligation to continue clinical management, parents have a directly parallel fiduciary responsibility to authorize such management. The goal of the discussion should be to prepare the parents for the shift from obstetric to neonatal ethics and the relatively diminished force of parental autonomy in the latter circumstance. We have argued that these parallel and mutually reinforcing fiduciary obligations are still substantial despite predicted caregiving burdens [1, 3].


References

  1. Chervenak FA, McCullough LB. Ethics in obstetrics and gynecology. An overview. Eur J Obstet Gynecol Reprod Biol. 1997;75(1):91-94.
  2. Fletcher JC, Isada NB, Pryde PG, Johnson MP, Evans MI. Fetal intracardiac potassium chloride injection to avoid the hopeless resuscitation of an abnormal abortus: II. Ethical issues. Obstet Gynecol. 1992;80(2):310-313.
  3. Chervenak FA, McCullough LB, Campbell S. Third trimester abortion: is compassion enough? Br J Obstet Gynaecol. 1999;106(4):293-296.
  4. McCullough LB. Neonatal ethics at the limits of viability. Pediatrics. 2005;116(4):1019-1021.
  5. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD; National Institute for Child Health and Human Development Neonatal Research Network. Intensive care for extreme prematurity—moving beyond gestational age. N Engl J Med. 2008;358(16):1672-1681.
  6. Chervenak FA, McCullough LB. The limits of viability. J Perinat Med. 1997;25(5):418-420.
  7. Chervenak FA, McCullough LB, Levene MI. An ethically justified, clinically comprehensive approach to peri-viability: gynaecological, obstetric, perinatal, and neonatal dimensions. J Obstet Gynaecol. 2007;27(1):3-7.

Frank A. Chervenak, MD, is the Given Foundation Professor and chairman of the Department of Obstetrics and Gynecology at Weill Medical College of Cornell University in New York.

Laurence B. McCullough, PhD, is the Dalton Tomlin Chair in Medical Ethics and Health Policy at the Baylor College of Medicine Center for Medical Ethics and Health Policy in Houston.

Saturday, October 4, 2008

U.S. to launch landmark child health study

$3.2 billion effort will follow 100,000 kids for two decades
Reuters
updated 2:24 p.m. ET, Fri., Oct. 3, 2008

WASHINGTON - A study that will cost $3.2 billion and last more than two decades to track the health of 100,000 U.S. children from before birth to age 21 will be launched in January, U.S. health officials said on Friday.

The National Children's Study will examine factors behind autism, cerebral palsy, learning disabilities, birth defects, attention deficit hyperactivity disorder, diabetes, asthma, heart disease, obesity and other conditions, the U.S. government's National Institutes of Health said.

NIH officials said they hope the study, to be conducted at 105 locations throughout the United States, can help pinpoint early-life influences that affect later development, with the goal of learning new ways to treat or prevent illness.

The study will examine hereditary and environmental factors such as exposure to certain chemicals that affect health.

Researchers will collect genetic and biological samples from people in the study as well as samples from the homes of the women and their babies including air, water, dust and materials used to construct their residences, the NIH said.

Officials said more than $200 million has been spent already and the study is projected to cost $3.2 billion.

"We anticipate that in the long term, what we learn from the study will result in a significant savings in the nation's health care costs," Dr. Duane Alexander, who heads the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development, told reporters.

Pregnant women will enroll in January
The study will begin in January when the University of North Carolina and the Mount Sinai School of Medicine in New York start signing up pregnant women whose babies would then be followed to age 21.

Some of the early findings will be about factors behind pre-term birth, which has become more common in recent years, according to Dr. Peter Scheidt of the NIH, who heads the study.

The first data from the study could be available in 2012 or 2013.

Scheidt said the study also may end up being the largest ever conducted with pregnant women.

The NIH on Friday named 27 institutions that will take part in the study. Nine others had been named previously and a few more are expected to be picked in the future, the NIH said.

The people taking part will be from rural, urban and suburban areas, from all income and educational levels and from all racial groups, the NIH said.

Friday, October 3, 2008

VM Oct. 1 - Ethically Responsible Use of NICU Capabilities

Resident editor introduces the October 2008 issue of Virtual Mentor on the topic of ethics in the neonatal intensive care unit.

This issue of Virtual Mentor explores the complex decisions that advances in neonatal intensive care have forced physicians, parents, and society to confront. The neonatal intensive care unit is widely celebrated as one of the great triumphs of the medical community in the past 30 years. Not only are NICUs credited with highly publicized cases of "miracle babies" born at the extremes of prematurity who go on to become highly successful members of society, they have also emerged as major profit-generating centers for financially challenged hospitals.

The threshold of viability—the age at which neonatologists will consider resuscitating premature infants—has dipped to 23 weeks' gestation in some centers. This increasingly early threshold for intervention, commonly viewed by the public as a medical triumph, has in turn decreased the gestational age at which obstetricians will perform invasive procedures for fetal well-being, often with major long-term morbidity for the mother. Although the overall survival of these extremely premature infants has increased with the development of sophisticated technological interventions, so too has our understanding of the serious short- and long-term sequelae of prematurity. The short-term morbidities associated with prematurity are described in this issue's clinical pearl by Tara Randis. Costs associated with intensive care as well as ongoing chronic care for long-term sequelae of prematurity are immense. Moreover, the ability of current treatments to bring extremely preterm infants to childhood both physically and neurologically intact remains tenuous. A large Norwegian cohort studied for 16 years showed increased medical and social disabilities in adults born at decreasing gestational ages, findings that compel us to question the true social cost of resuscitating increasingly premature infants [1].


Challenges for Physicians and Parents

Three clinical cases illustrate ethical challenges that confront NICU physicians. The first case, in which an infant with a possible diagnosis of trisomy 21 is born at 23 weeks' gestation, examines the limits of parental autonomy in determining whether to resuscitate the extremely preterm infant. Eric Eichenwald, Frank A. Chervenak, and Laurence B. McCullough summarize the clinical facts and physicians' ethical obligations that are critical in resolving disagreements between parents and physicians over resuscitation.

A NICU team struggles to make difficult treatment decisions in the absence of parent advocates in the second case, raising the question of whether it is possible to develop a rule-based approach to administration of neonatal care. Steve Leuthner and J.M. Lorenz argue that widely accepted, evidence-based guidelines for resuscitation have been forged, but no rules or guidelines can cover every possible case, and, when the limits of those guidelines are reached, physicians must determine the best interest of the infant at hand.

Balancing the interests of mother and fetus is a constant struggle for obstetricians who encounter women with medical conditions that necessitate delivery at the threshold of viability. The third case explores an obstetrician's dilemma in counseling a woman about a delivery mode that may subject the unborn fetus to significant morbidity and mortality. The reverse of this is also true. Anne Drapkin Lyerly describes the pitfalls in using nondirective counseling with patients concerning the mode of delivery for periviable fetuses. Lyerly makes a persuasive case for framing medical options in a way that offers parents socially and ethically sound choices.


Questions for Society

NICU successes and their place of prominence in U.S. hospitals entreat us to think about our shared social values. What does society's drive to exert effort and resources into resuscitating increasingly premature infants say about us? Does the fact that the Medicaid reimbursements for NICU care are among the program's highest reinforce the idea that we value supporting our most vulnerable members? Or, does it suggest an inability to regulate our own technological advances and an unwillingness to apply them in a more socially prudent manner?

In "Resuscitating the Extremely Low-Birth-Weight Infant: Humanitarianism or Hubris?" Patrick Jones and Brian Carter explain some of the social pressures for resuscitating extremely low-birth-weight infants. And Annie Janvier, in "Jumping to Premature Conclusions," describes how the goals of fertility specialists can conflict with those of neonatologists.

In their health policy commentary, "The Cost of Saving the Tiniest Lives: NICUs versus Prevention," Jonathan Muraskas and Kayhan Parsi detail the resources currently devoted to neonatal intensive care that may be better spent in prenatal care and prevention of preterm birth. Ferdinand Yates' op-ed piece exhorts physicians and parents to work together to decide on treatment for marginally viable premature infants that is in the infant's best interest.

Medical students' and residents' preparation to counsel women giving birth at the threshold of viability is a topic of urgent concern. Katherine Singh and Patrick Catalano describe the challenge of developing and teaching sound ethical judgment in the context of a rigorous obstetrical training program at a county hospital. In her personal narrative, Judette Louis offers her perspective on how delivering her own twins at 25 weeks' gestation altered the way she counsels high-risk patients facing a preterm birth.

Through these commentaries, Virtual Mentor readers are invited to explore their own attitudes toward prematurity. Those pursuing careers in pediatrics, neonatology, and obstetrics/gynecology will grapple daily with decisions about a patient's best interest—from pregnant women to prematurely born infants to concerned NICU parents. Please allow the commentaries and articles that follow to deepen your appreciation for the powerful therapeutic capacity of the NICU even as you develop a sense of our responsibility as physicians to implement this resource in a morally and socially responsible manner.


Reference

  1. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med. 2008;359(3):262-273.

Friday, September 19, 2008

What's Race Got to Do With It?

A new PBS documentary series explores the complicated and controversial connection between social inequality and health.

Raina Kelley

Newsweek Web Exclusive

Updated: 5:02 PM ET Apr 11, 2008

We're all the products of our environment and our genes. But when it comes to health, which factor is the trump card? Would a woman with a family propensity for ovarian cancer avoid coming down with the disease if she were raised on a macrobiotic diet in pollution-free rural North Dakota? Or on the flip side, could a white woman adopted from a middle-class family in Idaho into a poor Hispanic family in New York suddenly become vulnerable to diabetes or asthma?

Figuring out how the interplay of race, socioeconomic status, schooling and other environmental factors influences our health is a complicated challenge. But that's what a new four-hour PBS series, "Unnatural Causes: Is Inequality Making Us Sick?" aims to do. The series premiered March 27 and ends April 17 and will soon be released on DVD. Producers Larry Edelman and Llew Smith say it was inspired by a medical mystery they discovered in their earlier documentary, "Race—The Power of an Illusion, "a series that investigated some common myths and misconceptions about race. They found, for example, that African-Americans have some of the highest rates of hypertension in world, which has been linked to heredity. But West Africans, who share many of the same genes as African-Americans, have some of the lowest blood-pressure rates.

In "Unnatural Causes," the filmmakers raise other disturbing conundrums. For example, the United States spends more than twice the average of other industrialized countries on health care and yet does worse than 28 other countries in life expectancy and 29 other countries in infant mortality. Why are children living in poverty about seven times as likely to be in poor or fair health than children living in high-income households? And why has HIV infection doubled in the African-American population but remained stable among whites? According to the film, the answers are at least in part related to economic conditions, "a continuous health gradient tied to wealth. At each step down the socioeconomic ladder—from the rich to the middle class to the poor—people tend to be sicker and die sooner," the narrator says.

But that's not the whole story. African-Americans, Native Americans and Pacific Islanders at all income levels fare worse than their white counterparts. To the filmmakers, that seemed to indicate that institutional racism as well as poverty has an impact on an individual's health—an interesting idea in itself, and a refreshing relief from the patronizing assumption that "some people" don't know how to take care of themselves or don't make the effort. Smith says the film reveals a more complicated picture: "When we looked at populations and entire communities, you begin to see that there are larger forces at work beyond what an individual can control. That led us to the growing research focused on social determinants of health and health equity." The filmmakers offer plenty of background from experts like Angela Glover Blackwell, founder and CEO of PolicyLink, an advocacy organization for economic and social equity, and Ana Diez-Roux, M.D., a University of Michigan epidemiologist specializing in neighborhoods. But the film's power comes not from experts or statistics but stories of real people.

The first segment of the series, "In Sickness and in Wealth," looks at the lives of a CEO, a lab supervisor, a janitor and an unemployed mother to find out how class determines our access to health care. In "When the Bough Breaks," the filmmakers tell the story of Kim Anderson, a successful Atlanta attorney who, despite being healthy and well above the poverty level, delivers a dangerously premature daughter—a disproportionately common outcome for black women no matter their socioeconomic level. In "Becoming American," we meet Amador Bernal, an immigrant from Mexico who earns $9 an hour at a mushroom farm in Kennett Square, Pa. His health is beginning to suffer—but  Bernal has never been to a doctor.

One installment focuses on the Pima and the Tohono O'odham, two Native American tribes in Arizona. A century ago, type 2 diabetes was so rare as to be unheard of in this population. Today, these tribes have the highest rates of the disease in the world: filmmaker James Fortier draws a direct parallel between this fact and the loss of their water rights and farms.

Director Ellie Lee looks at two urban neighborhoods—Richmond, Calif., and Seattle—for a segment called "Place Matters." The Richmond area bears the hallmark lack of access to fresh food and safe streets that defines urban blight. In the Seattle community, leaders and government are working to create an area that promotes the health of its inhabitants. The differences in the residents' futures is stark, says the film. "If you lived in Richmond, you'd be 30 percent more likely to live into old age than if you lived in Seattle. In Richmond, your child would be six times more likely to be hospitalized for asthma than if you lived in Seattle."

The most damning indictment of the U.S. health-care system comes in the last two segments. "Collateral Damage" explores the effect on the lives and health of Marshall Islanders in the South Pacific since the Ronald Reagan Ballistic Missile Testing Site was located there—dislocating thousands of people, destroying their traditional way of life and resulting in a rise in tuberculosis and other diseases encouraged by squalid living conditions. And "Not Just a Paycheck" compares the socio-economic and health repercussions of an Electrolux factory closing in Greenville, Mich., with those in a Swedish community that had endured a similar factory shutdown. Hospital visits in Greenville tripled due to depression, alcoholism and heart disease. In Sweden, there was barely an increase in head colds: citizens there are protected by their country's generous social-welfare programs.

Some of the stories in "Unnatural Causes" are not entirely surprising (especially after Michael Moore's documentary "Sicko"), but they powerfully reinforce the fact that where you live can predict not just how well you live but also how long. According to the producers, more than 120 organizations from The Joint Center for Political and Economic Studies' Health Policy Institute to the Chi Eta Phi nursing sorority have begun to use this film as a teaching curriculum. Once you check out the series, you'll see why.

URL: http://www.newsweek.com/id/131597

©  2008 

Virtual Mentor, Sep #2 - Weighing the Duty to Inform a Patient of Possible Future Illness

American Medical Association Journal of Ethics
September 2008, Volume 10, Number 9: 553-555.
CLINICAL CASE

Commentary by Shannon Sullivan, MD

Mr. Watts went to see Dr. Pass, a specialist in sleep disorders, because of his history of violent behavior during sleep. Although Mr. Watts didn’t have any complaints, his wife was extremely frightened by the episodes of shouting, kicking, and punching that would occur while her husband was sleeping, usually in the early morning hours. After conducting a thorough history and physical exam, Dr. Pass was certain that the diagnosis was idiopathic REM sleep behavior disorder. Although Mr. Watts had always been healthy, Dr. Pass had seen in the literature that, with this diagnosis, Mr. Watts—now 58 years old—had a significant chance of developing a neurodegenerative disease within the next 10-15 years. He wondered whether he should tell Mr. Watts about his risk, given that there was some chance that he would not develop neurodegenerative disease. Whether or not he developed more serious disease later, Mr. Watts, currently an active, working attorney, might experience depression and grief if he were informed of this possibility. To complicate matters even more, there was nothing Mr. Watts or Dr. Pass could do now to prevent or delay onset of the disease.



Commentary

REM sleep behavior disorder (RBD) is a parasomnia that occurs during REM sleep and involves loss of normal REM-related skeletal muscle atonia. It is often associated with motor activity and the acting out of one’s dreams [1]. The condition is more common in men than in women and is often characterized by violent behaviors. Those with RBD have more aggressive dreams than those without the disorder, but this tendency does not carry over into the waking hours.

It has been proposed that many patients with “idiopathic” RBD are actually exhibiting early clinical signs of an evolving neurodegenerative disorder [1]. Current data indicate that approximately two-thirds of men aged 50 and older who are diagnosed with this disorder go on to develop Parkinson’s disease or a linked condition, dementia with Lewy bodies [2]. The average interval between the onset of RBD and the onset of classic Parkinson’s disease is about 13 years, but the time span can vary greatly. Interventions are available to treat the symptomatic manifestations of RBD, but there is no reliable neuroprotective treatment to slow onset or to reduce the risk of Parkinson’s disease. Ongoing research in this area could produce such protection within a decade.

Dr. Pass has a duty to make relevant information available to his patient [3]. This is one application of the principle of beneficence—the notion that the practitioner must act in the best interests of the patient. But this same duty to act in the patient’s best interest also invokes the principle of autonomy, which recognizes that competent individuals have a right to make their own health care decisions. Mr. Watts should be informed that his RBD places him at increased risk for being diagnosed with a neurodegenerative disease in the future because it may be important for planning and making decisions about relationships, retirement, finances, and travel. Although there is no neuroprotective treatment available now, Mr. Watts might benefit from discoveries made between the present and the onset of disease, if indeed he falls ill. Without knowledge of his increased risk, he will not be able to take advantage of new interventions should they become available. In these ways, information about his condition is likely to be relevant to Mr. Watts and should be communicated to him. Dr. Pass may also feel that withholding information about a patient’s health status is dishonest, insofar as omission of important details about his risk for disease is akin to avoiding part of the truth, as it is understood among experts in the medical community.

On the other hand, Dr. Pass must balance the duty to inform his patient with the principle of nonmaleficence, the ethics term for “first, do no harm.” One can argue that imposing on Mr. Watts the psychological burden of knowing that he is at increased risk for a neurodegenerative disease associated with dementia is not justifiable. This may be especially true if Dr. Pass has reasonable clinical suspicion that such knowledge will prompt Mr. Watts to develop depression or exacerbate other conditions, such as anxiety, that will impact his overall well-being. There is, after all, a reasonable chance (about 33 percent) that Mr. Watts will not develop neurodegenerative disease. Even if he is diagnosed in the future, the time until onset may be so long as to minimize the beneficial value of being informed now—a type of “future discounting.” If knowledge of disease risk is disclosed now, Mr. Watts will be burdened by the possibility of neurological deterioration at any time. Dr. Pass may deem these considerations, in combination with the lack of available treatment options, as insufficient justification for imposing potential emotional and psychological distress.

Dr. Pass may harm Mr. Watts to some degree either by informing him of the risk or by withholding the knowledge of future disease. Dr. Pass must weigh his duty to avoid psychologically burdening his patient unnecessarily against his duty to be truthful and forthcoming with important information and Mr. Watts’s right to know relevant medical information that may affect his future.
References
1. Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130(Pt 11):2770-2788.
2. Schenck C. What do parasomnias tell us about the brain? Presented at: Sleep Research Society Trainee Symposia; June 8, 2008; Baltimore MD.
554 Virtual Mentor, September 2008—Vol 10 www.virtualmentor.org
3. American Medical Association. Principles of medical ethics. Code of Medical Ethics. Chicago, IL: American Medical Association; 2008. http://www.ama-assn.org/ama/pub/category/2512.html. Accessed July 30, 2008.
Shannon Sullivan, MD, is a sleep physician at Stanford University Sleep Disorders Clinic in Palo Alto, California. She is also a pediatric pulmonologist and received her medical training at Stanford Medical Center; University of California, San Francisco; and University of Michigan Medical School. Her interests include respiratory physiology, cystic fibrosis, and sleep disorders associated with neurological disease.



The people and events in this case are fictional. Resemblance to real events or to names of people, living or dead, is entirely coincidental.

The viewpoints expressed on this site are those of the authors and do not necessarily reflect the views and policies of the AMA.

Copyright 2008 American Medical Association. All rights reserved.
www.virtualmentor.